Advertisement

Immediate and Intermediate Outcome After Transapical Versus Transfemoral Transcatheter Aortic Valve Replacement

Published:November 05, 2015DOI:https://doi.org/10.1016/j.amjcard.2015.10.036
      A few studies recently reported controversial results with transfemoral transcatheter aortic valve replacement (TF-TAVR) versus transapical transcatheter aortic valve replacement (TA-TAVR), often without adequate adjusted analysis for baseline differences. Data on patients who underwent TF-TAVR and TA-TAVR from the Observational Study of Effectiveness of avR–tavI procedures for severe Aortic stenosis Treatment study were analyzed with propensity score 1-to-1 matching. From a cohort of 1,654 patients (1,419 patients underwent TF-TAVR and 235 patients underwent TA-TAVR), propensity score matching resulted in 199 pairs of patients with similar operative risk (EuroSCORE II: TF-TAVR 8.1 ± 7.1% vs TA-TAVR, 8.4 ± 7.3%, p = 0.713). Thirty-day mortality was 8.0% after TA-TAVR and 4.0% after TF-TAVR (p = 0.102). Postoperative rates of stroke (TA-TAVR, 2.0% vs TF-TAVR 1.0%, p = 0.414), cardiac tamponade (TA-TAVR, 4.1% vs TF-TAVR 1.5%, p = 0.131), permanent pacemaker implantation (TA-TAVR, 8.7% vs TF-TAVR 13.3%, p = 0.414), and infection (TA-TAVR, 6.7% vs TF-TAVR 3.6%, p = 0.180) were similar in the study groups but with an overall trend in favor of TF-TAVR. Higher rates of major vascular damage (7.2% vs 1.0%, p = 0.003) and moderate-to-severe paravalvular regurgitation (7.8% vs 5.2%, p = 0.008) were observed after TF-TAVR. On the contrary, TA-TAVR was associated with higher rates of red blood cell transfusion (50.0% vs 30.4%, p = 0.0002) and acute kidney injury (stages 1 to 3: 44.4% vs 21.9%, p <0.0001) compared with TF-TAVR. Three-year survival rate was 69.1% after TF-TAVR and 57.0% after TA-TAVR (p = 0.006), whereas freedom from major adverse cardiovascular and cerebrovascular events was 61.9% after TF-TAVR and 50.4% after TA-TAVR (p = 0.011). In conclusion, TF-TAVR seems to be associated with significantly higher early and intermediate survival compared with TA-TAVR. The transfemoral approach, whenever feasible, should be considered the route of choice for TAVR.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Aguirre J.
        • Waskowski R.
        • Poddar K.
        • Kapadia S.
        • Krishnaswamy A.
        • McCullough R.
        • Mick S.
        • Navia J.L.
        • Roselli E.E.
        • Tuzcu M.E.
        • Sabik 3rd, J.F.
        • Lytle B.W.
        • Svensson L.G.
        Transcatheter aortic valve replacement: experience with the transapical approach, alternate access sites, and concomitant cardiac repairs.
        J Thorac Cardiovasc Surg. 2014; 148: 1417-1422
        • Bleiziffer S.
        • Ruge H.
        • Mazzitelli D.
        • Hutter A.
        • Opitz A.
        • Bauernschmitt R.
        • Lange R.
        Survival after transapical and transfemoral aortic valve implantation: talking about two different patient populations.
        J Thorac Cardiovasc Surg. 2009; 138: 1073-1080
        • Garcia D.C.
        • Benjo A.
        • Cardoso R.N.
        • Macedo F.Y.
        • Chavez P.
        • Aziz E.F.
        • Herzog E.
        • Alam M.
        • de Marchena E.
        Device stratified comparison among transfemoral, transapical and transubclavian access for transcatheter aortic valve replacement (TAVR): a meta-analysis.
        Int J Cardiol. 2014; 172: e318-e321
        • Li X.
        • Kong M.
        • Jiang D.
        • Dong A.
        Comparison 30-day clinical complications between transfemoral versus transapical aortic valve replacement for aortic stenosis: a meta-analysis review.
        J Cardiothorac Surg. 2013; 8: 168
        • Panchal H.B.
        • Ladia V.
        • Amin P.
        • Patel P.
        • Veeranki S.P.
        • Albalbissi K.
        • Paul T.
        A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events in patients undergoing transfemoral versus transapical transcatheter aortic valve implantation using edwards valve for severe aortic stenosis.
        Am J Cardiol. 2014; 114: 1882-1890
        • Takagi H.
        • Umemoto T.
        • ALICE (All-Literature Investigation of Cardiovascular Evidence) Group
        A meta-analysis of adjusted observational studies for mortality in transapical versus transfemoral aortic valve implantation.
        Int J Cardiol. 2014; 174: 165-170
        • Walther T.
        • Kempfert J.
        Transapical vs. transfemoral aortic valve implantation: which approach for which patient, from a surgeon's standpoint.
        Ann Cardiothorac Surg. 2012; 1: 216-219
        • D'Errigo P.
        • Fusco D.
        • Grossi C.
        • Ramondo A.B.
        • Ranucci M.
        • Santini F.
        • Santoro G.
        • Seccareccia F.
        • Tamburino C.
        OBSERVANT: observational study of appropriateness, efficacy and effectiveness of AVR-TAVI procedures for the treatment of severe symptomatic aortic stenosis. Study protocol.
        G Ital Cardiol. 2010; 11: 897-909
        • Tamburino C.
        • Barbanti M.
        • D'Errigo P.
        • Ranucci M.
        • Onorati F.
        • Covello R.D.
        • Santini F.
        • Rosato S.
        • Santoro G.
        • Fusco D.
        • Grossi C.
        • Seccareccia F.
        • OBSERVANT Research Group
        1-year outcomes after transfemoral transcatheter or surgical aortic valve replacement: results from the Italian OBSERVANT study.
        J Am Coll Cardiol. 2015; 66: 804-812
        • D'Errigo P.
        • Barbanti M.
        • Ranucci M.
        • Onorati F.
        • Covello R.D.
        • Rosato S.
        • Tamburino C.
        • Santini F.
        • Santoro G.
        • Seccareccia F.
        • OBSERVANT Research Group
        Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis: results from an intermediate risk propensity-matched population of the Italian OBSERVANT study.
        Int J Cardiol. 2013; 167: 1945-1952
        • Austin P.C.
        Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies.
        Pharm Stat. 2011; 10: 150-161
        • Van der Boon R.M.
        • Marcheix B.
        • Tchetche D.
        • Chieffo A.
        • Van Mieghem N.M.
        • Dumonteil N.
        • Vahdat O.
        • Maisano F.
        • Serruys P.W.
        • Kappetein A.P.
        • Fajadet J.
        • Colombo A.
        • Carrié D.
        • van Domburg R.T.
        • de Jaegere P.P.
        Transapical versus transfemoral aortic valve implantation: a multicenter collaborative study.
        Ann Thorac Surg. 2014; 97: 22-28
        • Himbert D.
        • Descoutures F.
        • Al-Attar N.
        • Iung B.
        • Ducrocq G.
        • Détaint D.
        • Brochet E.
        • Messika-Zeitoun D.
        • Francis F.
        • Ibrahim H.
        • Nataf P.
        • Vahanian A.
        Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis.
        J Am Coll Cardiol. 2009; 54: 303-311
        • Gilard M.
        • Eltchaninoff H.
        • Iung B.
        • Donzeau-Gouge P.
        • Chevreul K.
        • Fajadet J.
        • Leprince P.
        • Leguerrier A.
        • Lievre M.
        • Prat A.
        • Teiger E.
        • Lefevre T.
        • Himbert D.
        • Tchetche D.
        • Carrié D.
        • Albat B.
        • Cribier A.
        • Rioufol G.
        • Sudre A.
        • Blanchard D.
        • Collet F.
        • Dos Santos P.
        • Meneveau N.
        • Tirouvanziam A.
        • Caussin C.
        • Guyon P.
        • Boschat J.
        • Le Breton H.
        • Collart F.
        • Houel R.
        • Delpine S.
        • Souteyrand G.
        • Favereau X.
        • Ohlmann P.
        • Doisy V.
        • Grollier G.
        • Gommeaux A.
        • Claudel J.P.
        • Bourlon F.
        • Bertrand B.
        • Van Belle E.
        • Laskar M.
        • FRANCE 2 Investigators
        Registry of transcatheter aortic-valve implantation in high-risk patients.
        N Engl J Med. 2012; 366: 1705-1715
        • Ribeiro H.B.
        • Dahou A.
        • Urena M.
        • Carrasco J.L.
        • Mohammadi S.
        • Doyle D.
        • Le Ven F.
        • Allende R.
        • Amat-Santos I.
        • Paradis J.M.
        • DeLarochellière R.
        • Puri R.
        • Abdul-Jawad Altisent O.
        • Del Trigo M.
        • Campelo-Parada F.
        • Pibarot P.
        • Dumont É.
        • Rodés-Cabau J.
        Myocardial injury after transaortic versus transapical transcatheter aortic valve replacement.
        Ann Thorac Surg. 2015; 99: 2001-2009
        • Barbash I.M.
        • Dvir D.
        • Ben-Dor I.
        • Corso P.J.
        • Goldstein S.A.
        • Wang Z.
        • Bond E.
        • Okubagzi P.G.
        • Satler L.F.
        • Pichard A.D.
        • Waksman R.
        Impact of transapical aortic valve replacement on apical wall motion.
        J Am Soc Echocardiogr. 2013; 26: 255-260
        • Zacharias M.
        • Mugawar M.
        • Herbison G.P.
        • Walker R.J.
        • Hovhannisyan K.
        • Sivalingam P.
        • Conlon N.P.
        Interventions for protecting renal function in the perioperative period.
        Cochrane Database Syst Rev. 2013; 9: CD003590
        • Athappan G.
        • Gajulapalli R.D.
        • Sengodan P.
        • Bhardwaj A.
        • Ellis S.G.
        • Svensson L.
        • Tuzcu E.M.
        • Kapadia S.R.
        Influence of transcatheter aortic valve replacement strategy and valve design on stroke after transcatheter aortic valve replacement: a meta-analysis and systematic review of literature.
        J Am Coll Cardiol. 2014; 63: 2101-2110
        • Rodés-Cabau J.
        • Dumont E.
        • Boone R.H.
        • Larose E.
        • Bagur R.
        • Gurvitch R.
        • Bédard F.
        • Doyle D.
        • De Larochellière R.
        • Jayasuria C.
        • Villeneuve J.
        • Marrero A.
        • Côté M.
        • Pibarot P.
        • Webb J.G.
        Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches.
        J Am Coll Cardiol. 2011; 57: 18-28
        • Czerwinska-Jelonkiewicz K.
        • Michalowska I.
        • Witkowski A.
        • Dabrowski M.
        • Ksiezycka-Majczynska E.
        • Chmielak Z.
        • Kusmierski K.
        • Hryniewiecki T.
        • Demkow M.
        • Stepinska J.
        Vascular complications after transcatheter aortic valve implantation (TAVI): risk and long-term results.
        J Thromb Thrombolysis. 2014; 37: 490-498
        • Leon M.B.
        • Piazza N.
        • Nikolsky E.
        • Blackstone E.H.
        • Cutlip D.E.
        • Kappetein A.P.
        • Krucoff M.W.
        • Mack M.
        • Mehran R.
        • Miller C.
        • Morel M.A.
        • Petersen J.
        • Popma J.J.
        • Takkenberg J.J.
        • Vahanian A.
        • Van Es G.A.
        • Vranckx P.
        • Webb J.G.
        • Windecker S.
        • Serruys P.W.
        Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials a consensus report from the Valve Academic Research Consortium.
        J Am Coll Cardiol. 2011; 57: 253-269